Tonix Pharm Holdings (TNXP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
17.82 +0.63 (+3.66%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 17.36 -0.46 (-2.58%) 19:53 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -130,036 | -116,658 | -110,218 | -92,287 | -50,463 |
Depreciation Amortization | 4,261 | 4,291 | 1,253 | 50 | 27 |
Accounts receivable | -3,683 | N/A | N/A | N/A | N/A |
Accounts payable and accrued liabilities | 927 | -3,490 | -1,045 | 3,526 | 1,528 |
Other Working Capital | 5,775 | -35 | -2 | 5,781 | -2,366 |
Other Operating Activity | 61,831 | 13,889 | 11,959 | 7,373 | 2,708 |
Operating Cash Flow | $-60,925 | $-102,003 | $-98,053 | $-75,557 | $-48,566 |
Cash Flows From Investing Activities | |||||
PPE Investments | -120 | -6,896 | -48,147 | -35,307 | -8,564 |
Net Acquisitions | N/A | -22,174 | N/A | N/A | N/A |
Investing Cash Flow | $-120 | $-29,070 | $-48,147 | $-35,307 | $-8,564 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 8,942 | N/A | N/A | N/A |
Common Stock Issued | 140,222 | 41,540 | 94,503 | 212,487 | 118,503 |
Common Stock Repurchased | N/A | -13,965 | N/A | N/A | N/A |
Other Financing Activity | -5,350 | 0 | -6,659 | 0 | 4,602 |
Financing Cash Flow | $134,872 | $36,517 | $87,844 | $212,487 | $123,105 |
Exchange Rate Effect | 4 | -65 | -74 | -31 | -16 |
Beginning Cash Position | 25,849 | 120,470 | 178,900 | 77,308 | 11,349 |
End Cash Position | 99,680 | 25,849 | 120,470 | 178,900 | 77,308 |
Net Cash Flow | $73,831 | $-94,621 | $-58,430 | $101,592 | $65,959 |
Free Cash Flow | |||||
Operating Cash Flow | -60,925 | -102,003 | -98,053 | -75,557 | -48,566 |
Capital Expenditure | -120 | -7,895 | -48,147 | -35,307 | -8,564 |
Free Cash Flow | -61,045 | -109,898 | -146,200 | -110,864 | -57,130 |